COMP <GO>
IMMR vs NVDA // 10Y YIELD & FRED MACRO BETA
Immersion Corporation (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: IMMR 4
— NVDA 8
■ METRIC PARITY
LAST: $7.30 (+0.97%) • MKT CAP: $242.4M
macro-sensitivity
—
LAST: $213.66 (-0.80%) • MKT CAP: $5.15T
macro-sensitivity
2.04
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IMMR VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IMMR | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.67% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.40% | 65.06% | -52.66 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.1x | 23.2x | -20.11 | IMMR | /valuation <GO> |
| Free Cash Flow Yield | 17.69% | 2.58% | +15.11 | IMMR | /fcf-yield <GO> |
| Operating Margin | 1.50% | 65.21% | -63.71 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 0.30% | 63.66% | -63.36 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 83.38% | -72.18 | NVDA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.32% | 0.02% | +3.30 | IMMR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.85 | 19.52 | -17.67 | NVDA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 4/9 | +2.00 | IMMR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 9.01% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.8 | 51.1 | -2.34 | NVDA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 2.04 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 49.8x | 17.0x | +32.78 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $242.4M | $5.15T | -$5.15T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IMMR REV | NVDA REV | IMMR GROSS % | NVDA GROSS % | IMMR FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $1.73B | $130.50B | — | 75.0% | $42.9M | $60.85B |
| FY 2024 | $1.56B | $60.92B | — | 72.7% | -$68.8M | $27.02B |
| FY 2023 | $33.9M | $26.97B | — | 56.9% | $20.6M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IMMR // BETA —
NVDA // BETA 2.04